|
SHARE BASED COMPENSATION (Tables)
|
12 Months Ended |
|
Mar. 31, 2014
|
| SHARE BASED COMPENSATION |
|
| Schedule of stock options activity |
|
|
|
|
|
Weighted
|
|
Weighted
|
|
Aggregate
|
|
|
|
|
|
|
average
|
|
remaining
|
|
intrinsic
|
|
|
|
|
Number of
|
|
exercise
|
|
contractual
|
|
value
|
|
|
|
|
shares
|
|
USD
|
|
Years
|
|
USD
|
|
|
Outstanding as of March 31, 2011
|
|
3,262,650
|
|
2.96
|
|
|
|
|
|
|
Granted
|
|
—
|
|
—
|
|
|
|
|
|
|
Exercised
|
|
(27,864
|
)
|
3.60
|
|
|
|
|
|
|
Forfeited
|
|
—
|
|
—
|
|
|
|
|
|
|
Expired
|
|
(446,444
|
)
|
3.60
|
|
|
|
|
|
|
Outstanding as ofMarch 31, 2012
|
|
2,788,342
|
|
2.85
|
|
|
|
|
|
|
Granted
|
|
—
|
|
—
|
|
|
|
|
|
|
Exercised
|
|
—
|
|
—
|
|
|
|
|
|
|
Forfeited
|
|
—
|
|
—
|
|
|
|
|
|
|
Expired
|
|
(41,000
|
)
|
3.60
|
|
|
|
|
|
|
Outstanding as ofMarch 31, 2013
|
|
2,747,342
|
|
2.84
|
|
|
|
|
|
|
Granted
|
|
1,469,460
|
|
2.50
|
|
|
|
|
|
|
Exercised
|
|
—
|
|
—
|
|
|
|
|
|
|
Forfeited
|
|
—
|
|
—
|
|
|
|
|
|
|
Expired
|
|
(2,135
|
)
|
2.69
|
|
|
|
|
|
|
Outstanding as ofMarch 31, 2014
|
|
4,214,667
|
|
2.72
|
|
|
|
|
|
|
Vested and expected to vest as of March 31, 2014
|
|
4,214,667
|
|
2.72
|
|
4.68
|
|
Nil
|
|
|
Exercisable as of March 31, 2014
|
|
2,745,207
|
|
2.84
|
|
2.09
|
|
Nil
|
|
|
| Schedule of information relating to options outstanding and exercisable |
|
Options outstanding as of March 31, 2014
|
|
Options exercisable as of March 31, 2014
|
|
|
|
|
Exercise
|
|
Remaining
|
|
|
|
Exercise
|
|
Remaining
|
|
|
Number of
|
|
Price
|
|
Contractual
|
|
Number
|
|
Price
|
|
Contractual
|
|
|
Shares
|
|
per Share
|
|
Life
|
|
of Shares
|
|
per Share
|
|
Life
|
|
|
|
|
USD
|
|
Years
|
|
|
|
USD
|
|
Years
|
|
|
1,312,600
|
|
2.26
|
|
1.1
|
|
1,312,600
|
|
2.26
|
|
1.1
|
|
|
674,000
|
|
3.60
|
|
1.7
|
|
674,000
|
|
3.60
|
|
1.7
|
|
|
250,000
|
|
3.60
|
|
2.6
|
|
250,000
|
|
3.60
|
|
2.6
|
|
|
101,000
|
|
3.60
|
|
3.7
|
|
101,000
|
|
3.60
|
|
3.7
|
|
|
100,000
|
|
4.75
|
|
3.5
|
|
100,000
|
|
4.75
|
|
3.5
|
|
|
7,607
|
|
2.69
|
|
4.9
|
|
7,607
|
|
2.69
|
|
4.9
|
|
|
300,000
|
|
2.12
|
|
6.0
|
|
300,000
|
|
2.12
|
|
6.0
|
|
|
1,469,460
|
|
2.50
|
|
9.5
|
|
—
|
|
2.50
|
|
9.5
|
|
|
4,214,667
|
|
2.72
|
|
4.68
|
|
2,745,207
|
|
2.84
|
|
2.09
|
|
|
| Summary of assumptions used in the valuation model |
|
|
|
Year Ended March 31,
|
|
|
|
|
2012
|
|
2013
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
Expected dividend yield
|
|
—
|
|
—
|
|
0%
|
|
|
Expected volatility
|
|
—
|
|
—
|
|
75%
|
|
|
Expected term
|
|
—
|
|
—
|
|
6.25
|
|
|
Risk-free interest rate (per annum)
|
|
—
|
|
—
|
|
1.77%
|
|
|
| SHARE BASED COMPENSATION |
|
| Summary of the nonvested share activities |
|
|
|
|
|
Weighted
average
|
|
|
|
|
Number
|
|
grant date
|
|
|
|
|
of shares
|
|
fair value
|
|
|
|
|
|
|
USD
|
|
|
Outstanding at March 31, 2011
|
|
306,000
|
|
2.949
|
|
|
Granted
|
|
1,060,000
|
|
4.963
|
|
|
Vested
|
|
(116,245
|
)
|
2.076
|
|
|
Forfeited
|
|
(103,005
|
)
|
4.470
|
|
|
Outstanding at March 31, 2012
|
|
1,146,750
|
|
4.788
|
|
|
Granted
|
|
100,000
|
|
2.015
|
|
|
Vested
|
|
(334,250
|
)
|
(4.348
|
)
|
|
Forfeited
|
|
(17,500
|
)
|
1.904
|
|
|
Outstanding at March 31, 2013
|
|
895,000
|
|
4.633
|
|
|
Granted
|
|
280,000
|
|
2.145
|
|
|
Vested
|
|
(265,000
|
)
|
4.963
|
|
|
Forfeited
|
|
(100,000
|
)
|
2.015
|
|
|
Outstanding at March 31, 2014
|
|
810,000
|
|
3.989
|
|
|
|
Options
|
|
| SHARE BASED COMPENSATION |
|
| Schedule of allocation of recognized compensation expense |
|
|
|
Year Ended March 31,
|
|
|
|
|
2012
|
|
2013
|
|
2014
|
|
|
|
|
RMB
|
|
RMB
|
|
RMB
|
|
|
Cost of revenues
|
|
—
|
|
—
|
|
—
|
|
|
Research and development
|
|
—
|
|
—
|
|
—
|
|
|
Sales and marketing
|
|
42,914
|
|
—
|
|
—
|
|
|
General and administrative
|
|
547,231
|
|
306,659
|
|
3,946,384
|
|
|
Total share based compensation expense
|
|
590,145
|
|
306,659
|
|
3,946,384
|
|
|
|
Nonvested shares
|
|
| SHARE BASED COMPENSATION |
|
| Schedule of allocation of recognized compensation expense |
|
|
|
Year Ended March 31,
|
|
|
|
|
2012
|
|
2013
|
|
2014
|
|
|
|
|
RMB
|
|
RMB
|
|
RMB
|
|
|
Cost of revenues
|
|
71,691
|
|
21,813
|
|
228,854
|
|
|
Research and development
|
|
189,462
|
|
308,577
|
|
336,869
|
|
|
Sales and marketing
|
|
344,226
|
|
702,683
|
|
454,503
|
|
|
General and administrative
|
|
11,068,873
|
|
10,239,490
|
|
5,568,300
|
|
|
Total share based compensation expense
|
|
11,674,252
|
|
11,272,563
|
|
6,588,526
|
|
|